Overview
Perimenopause is the transition leading to menopause, and menopause is identified after 12 consecutive months without a menstrual period when no other cause explains it. Treatment can include education, symptom-specific nonhormonal strategies, nonhormonal prescriptions, or menopausal hormone therapy for appropriately selected women. Benefits, risks, route, dose, alternatives, and follow-up must be individualized.
At a Glance
- Focuses specifically on perimenopause, menopause, and related symptoms.
- Uses symptoms, age, menstrual history, medical history, and risk review.
- Does not require broad hormone testing for every patient.
- Discusses hormonal and nonhormonal options.
- Recognizes that hormone therapy is effective for certain symptoms but not appropriate for everyone.
- Addresses safety, contraindications, monitoring, and changing needs over time.
- Keeps broader women's hormone questions on the women's page.
What are perimenopause and menopause?
Perimenopause is the time when ovarian function and menstrual patterns begin to change before the final menstrual period. Symptoms may begin while periods continue and may vary over time. Menopause is generally recognized after 12 months without a period in the absence of another cause. Surgical or treatment-induced menopause can follow removal of the ovaries or certain medical therapies and may need different consideration.
The transition is not identical for every woman. Some have minimal symptoms. Others experience concerns that substantially affect sleep, work, relationships, or quality of life.
What symptoms may be associated with the menopause transition?
Symptoms can include hot flashes, night sweats, sleep disturbance, cycle changes, vaginal dryness, urinary symptoms, discomfort with sex, mood changes, and concentration concerns. Weight and body-composition changes may occur in midlife, but they are influenced by many factors and should not automatically be attributed to one hormone.
Symptoms can overlap with pregnancy, thyroid disorders, anemia, medication effects, mood disorders, sleep disorders, infection, gynecologic conditions, and other medical problems. New, severe, or unusual symptoms deserve appropriate evaluation.
Who may be appropriate for menopause care?
This service may fit women who:
- Have bothersome symptoms during perimenopause or after menopause.
- Want to understand whether symptoms fit the menopause transition.
- Need a review of hormonal and nonhormonal options.
- Are already using hormone therapy and want to review benefit, risk, route, dose, or monitoring.
- Have metabolic or body-composition concerns that need a broader medical assessment.
- Want coordination with gynecology, primary care, or other specialists.
Unexplained bleeding, a breast concern, severe pelvic pain, suspected pregnancy, or other red flags may require prompt gynecologic or urgent evaluation.
What may the evaluation include?
Symptom and menstrual history
The physician reviews symptoms, bleeding patterns, last menstrual period, prior surgery, contraception, pregnancy possibility, sexual and urinary concerns, sleep, mood, and effect on daily life.
Medical and family history
The discussion may include cancer history, blood clots, cardiovascular disease, stroke, liver disease, migraines, osteoporosis risk, medications, and family history. These details can affect whether a treatment is reasonable.
Examination and testing
Many otherwise healthy women of typical age can be assessed clinically, while testing may be useful when the diagnosis is uncertain or another condition is suspected. Testing should be targeted rather than a universal hormone panel.
Review of preventive needs
Menopause care can include coordination of age and risk-based screening, bone health, cardiovascular risk, sleep, sexual health, and other preventive concerns.
What treatment options may be discussed?
Education and practical symptom measures
Understanding triggers, sleep patterns, clothing or temperature strategies, vaginal moisturizers or lubricants, and other practical measures may help some symptoms. Recommendations should be matched to the concern and evidence.
Nonhormonal prescriptions
Several prescription approaches may be considered for certain symptoms when hormone therapy is not desired or appropriate. Choice depends on symptoms, health history, interactions, side effects, and preferences.
Menopausal hormone therapy
Hormone therapy can be effective for vasomotor symptoms and genitourinary symptoms in appropriately selected women. The Menopause Society's 2022 position statement emphasizes individualized decision-making. ACOG's patient guidance also describes benefits and risks that vary by the individual and regimen.
The specific hormone, route, dose, and need for endometrial protection depend on anatomy, symptoms, and health history.
Local treatment for genitourinary symptoms
Some treatments act primarily in vaginal or urinary tissues and may have different considerations from systemic therapy.
What changed in FDA menopause hormone labeling in 2026?
On February 12, 2026, the FDA announced approved labeling changes for six menopausal hormone therapy products to clarify benefit-risk considerations and remove certain boxed-warning language. The change does not make hormone therapy risk-free or appropriate for every woman. Product-specific labeling and individualized clinical judgment still matter. See the FDA announcement and current product information.
How does the care process work?
- Request a consultation and confirm the service scope, fee, and availability.
- Complete secure intake and provide prior records, screening history, and current medications.
- Meet with a physician for symptom, menstrual, reproductive, and medical-risk review.
- Complete targeted examination or testing when indicated and available.
- Discuss hormonal and nonhormonal options, expected benefits, risks, alternatives, and uncertainty.
- Choose a plan or decide to observe or refer.
- Follow up to assess symptom response, side effects, safety, and whether the plan remains appropriate.
How does Vitruvian approach menopause care?
The approach is neither automatic treatment nor automatic refusal. Women should receive clear information and have their symptoms taken seriously. At the same time, no therapy should be sold as universally safe, anti-aging, or preventive of every chronic disease. Decisions should reflect the individual's priorities, health history, and changing evidence.
If metabolic or body-composition concerns are important, the physician may evaluate them separately rather than promising that hormone therapy will cause weight loss. A natural link to Medical Weight Management may be appropriate when that program is confirmed.
Important limitations and safety considerations
- Hormone therapy is not appropriate for every woman.
- Risks vary by product, route, dose, duration, timing, anatomy, and medical history.
- Unexplained bleeding requires evaluation.
- Hormone therapy should not be marketed as a general anti-aging treatment or guaranteed weight-loss method.
- Compounded menopausal hormone products are not FDA-approved as finished products and should not be described as safer by default. See ACOG's clinical consensus.
- Symptom improvement may be incomplete, and treatment may need adjustment or discontinuation.
- Routine follow-up and age-appropriate preventive care remain important.
Frequently Asked Questions
How do I know if I am in perimenopause?
Age, symptoms, and changes in menstrual patterns often provide important clues. Testing may be useful in selected situations, but one hormone level does not always establish the transition.
Is hormone therapy safe?
Safety depends on the individual and the specific regimen. A clinician should discuss expected benefits, risks, alternatives, and product labeling.
Do I need progesterone?
The answer depends on the treatment and whether a uterus is present, among other factors. This requires individual prescribing guidance.
Does hormone therapy cause breast cancer?
Risk cannot be reduced to a yes-or-no slogan. It varies with regimen, duration, baseline risk, and other factors. A physician should discuss the evidence relevant to the individual.
Will hormone therapy help me lose weight?
It should not be promised as a weight-loss treatment. Midlife weight concerns deserve a broader metabolic, behavioral, and medical evaluation.
Are compounded hormones better?
Compounded products are not FDA-approved as finished products, and they should not be presumed safer or more effective than approved options.
How often will I need follow-up?
The schedule depends on symptoms, treatment, health history, and safety needs.
References
Medical Disclaimer
This page provides general education and does not diagnose menopause, recommend a product, or replace individualized care. Do not start, stop, or change prescribed therapy without guidance from the treating clinician.